Externalizing discovery screening processes can help with focusing on adding value in-house but it's important to preserve the efficiency and integrity of your data value chain
Join Andy Vines of IDBS and Jim Silva of Pfizer Inc. as they explore successful approaches to externalization in the drug discovery space. In this session, Andy will take a closer look at the issues around making sure that data generated externally can be easily shared, incorporated back into in-house-systems and that its integrity and transparency leads to fully reproducible results.
Jim will be sharing his experience of making collaboration work at Pfizer Inc., and together, both speakers will examine models of collaboration, highlighting best practice for collaboration in life sciences.
Andy Vines,
Product Manager, Screening Solutions, IDBS
With an academic background in pharmacology and biochemistry, Andy Vines is currently the Product Manager responsible for IDBS' screening solutions, including the ActivityBase Suite, ActivityMart and XLfit.
Before joining IDBS in 2008, Andy had already gained extensive user experience of ActivityBase, having used it in his previous R&D-centric roles at GlaxoSmithKline (GSK). During an industry career spanning 20 years, Andy was instrumental in driving forward a number of research programs in oncology and cardiovascular therapeutic areas, primarily in research biology and screening functions covering target ID, hit ID, lead optimization and candidate selection.
His industry expertise and experience of discovery screening place him in an excellent position to advise R&D specialists on how IDBS can help them overcome the many challenges facing a fast-evolving scientific domain.
Jim Silva,
Senior Manager Business Partner, Pfizer Inc.
Jim Silva is Senior Manager, Strategic Business Partner in Research Business Technology at Pfizer Inc. He is responsible for developing information technology strategies to support global pharmacology and the pharmacokinetics, dynamics and metabolism group in Research at Pfizer Inc.
Previously, Jim was the business partner for the cardiovascular, metabolic and endocrine diseases research unit in Groton, CT. He began his 16 year Pfizer Inc. career as a scientific applications developer in discovery informatics, supporting supply chain activities and has held several roles of increasing responsibility since, including as a domain architect supporting drug safety research and development.
Jim holds an MS and BS in Computer Science from the University of New Haven.
- Approaching externalization – understanding your options
- Making externalization a reality – getting the infrastructure right
- Successful externalization – don’t compromise on the efficiency of your data value chain
- Externalize costs, internalize value – achieving results that matter
- Screening
- Research and Discovery
- IT Managers
- R&D IT Managers
- CRO Managers
